Patient-Reported Outcomes Promos Need “Substantial Evidence,” FDA Says

Promotion using patient reported outcomes requires "substantial evidence" supporting patients' claims, FDA Division of Drug Marketing, Advertising & Communication's Director Thomas Abrams said